Revolutionizing Regenerative Medicine: The Potential of Stem Cells and S.O.N.G. Laser Technology

Stem cells are transforming regenerative medicine, with a special focus on VSEL stem cells and the innovative S.O.N.G. Laser technology. It is estimated that a human body contains 37 trillion cells, of which approximately 50,000 to 200,000 are stem cells. This makes stem cells relatively rare in the body, yet utterly essential for our daily existence.

With a solid background at the University of Cambridge and academic experience in Cambridge and London, I have dedicated myself to demystifying the complexity of medicine in general, especially VSEL stem cells and the innovative S.O.N.G. Laser technology for students and readers.

After more than four decades in regenerative medicine, I am convinced that VSEL stem cells activated by the S.O.N.G. Laser represent a realistic, cost-effective, safe, and efficient future in this field.

As a physician, scientist, and author of the ‘Medicine Demystified’ series, I have explored topics such as stem cell technology in Regenerative Medicine and fertility.

This capacity of VSEL stem cells is the basis of Regenerative Medicine because they are used to treat various diseases that require repair and regeneration of cells and tissues.

Moreover, one of the most recent innovations in this area is the use of the S.O.N.G. Laser, developed by Dr. Todd Ovokaitys, which represents a significant advancement in the activation of VSEL stem cells.

Regenerative medicine is moving very rapidly towards clinical acceptance for a variety of conditions, and VSEL stem cells activated by the S.O.N.G. Laser are leading the way.

Our daily healthy lives entirely depend on stem cells. If they fail in some way, they can result in serious and even fatal diseases.

The most studied stem cell is found in the bone marrow and is crucial for the daily production of blood cells.

Another good example is the skin’s stem cells, which repair daily “wear and tear” and can be seen in action when they “magically” heal wounds on the skin.

A scar, for example, may result from large wounds, but the skin repair process is nevertheless extremely impressive.

It is also interesting to note that skin aging is simply due to the aging of stem cells in this area.

As a professor in this field, I have observed the successful use of bone marrow stem cells in treating blood disorders like leukemia. This is the oldest example of Regenerative Medicine, a fact that is proven and tested.

Moreover, bone marrow stem cell transplantation to treat blood disorders is now routine clinical practice worldwide.

The potential of induced pluripotent stem cells (iPSC) and embryonic stem cells (ESC) has also been studied, although they face challenges such as cost and safety in clinical practice.

VSEL stem cells, meanwhile, are fascinating due to their tiny size (approximately 2 to 4 millionths of a meter in diameter), allowing them to access all parts of the body.

In contrast, there are other stem cells for therapeutic use and clinical trial, but they are so physically large that when administered intravenously most of them get stuck in the lungs.

Although VSEL stem cells are similar to embryonic (ESC) in some surface properties, this does not mean they are ESC.

VSEL stem cells carry some molecules on the cell surface that are similar to embryonic stem cells. The key message here is that VSEL stem cells are not embryonic stem cells.

VSEL stem cells can produce every type of tissue, which makes them ideal candidates for regenerative treatments; in theory, they can be used to treat any disease.

Another advantage of VSEL stem cells is that they are found in large quantity and quality regardless of a person’s age, so everyone’s body carries these cells throughout their life.

One of the main places where VSEL stem cells are found is in the bloodstream, making it very easy to obtain some VSEL stem cells by taking a simple blood sample.

This is very different from other types of stem cells that have complex and often painful collection procedures. Most of these other stem cells are allogeneic, meaning they are donated.

The S.O.N.G. Laser is a safe and effective method to activate VSEL stem cells extracted from the blood and may be able to “guide” these cells to the treatment site, known as “relocation”.

This harmless and highly specialized laser “activates” the VSEL stem cells so that they become biologically active for effective treatments.

We have already conducted considerable clinical research on the S.O.N.G. Laser using it on VSEL stem cells obtained from human blood.

The ease of obtaining these cells from the blood and reintroducing them to the patient after laser treatment is a notable advantage.

The laser “activates” the VSEL stem cells in such a way that when the VSEL stem cells treated with the S.O.N.G. Laser are returned to the patient, they are biologically active and have shown great benefits for some patients.

Interestingly, the VSEL stem cells are obtained from the patient through a simple blood extraction, which is treated with the S.O.N.G. Laser and then returned to the same patient.

The use of VSEL stem cells activated by the S.O.N.G. Laser has shown promising results in conditions such as end-stage heart failure; neurological diseases like Alzheimer’s, dementia, and stroke; traumas like spinal cord injury and traumatic brain injury; and type 2 diabetes.

Furthermore, its potential for longevity, fertility, and soft tissue regeneration is being investigated. The therapy with activated VSEL stem cells might also influence skin repair and rejuvenation, although more research is required to confirm this possibility.

VSEL stem cells activated by S.O.N.G. Laser may reduce biological age. Some people suggest that therapy with these cells can result in the repair or rejuvenation of the skin. However, much more work is needed to confirm this claim.

Indeed, the mechanism of action in this particular is not yet understood, but it may be that VSEL stem cells activated by S.O.N.G. Laser modulate age-related changes in our DNA.

It is possible that the regeneration of soft tissues, including cartilage, ligaments, and tendons, may be possible through therapy with VSEL stem cells activated by the S.O.N.G. Laser.

This may be useful for older individuals and athletes who may have suffered joint or soft tissue injuries.

Peter was trained at the University of Cambridge under the supervision of the IVF co-inventor and Nobel Prize winner, Professor Sir Bob Edwards FRS. His Ph.D. was in stem cell technology with a focus on the transplantation of stem cells from the developing mouse fetus.

His postdoctoral position was as a Senior Embryologist at the Bourn Hall Clinic, which was the world’s first IVF clinic.

Peter has been the scientific director of Cells for Life in Toronto and Smart Cells in the UK and was appointed by the HTA for Smart Cells.

He has conducted research and clinical practice in stem cell technology and IVF and has written numerous articles and book chapters on stem cell technology and IVF.

He has also been a guest speaker at many international conferences, including personal invitations to speak twice at the Vatican, the UK House of Lords, and the Canadian Parliament.

In addition, he has experience in creating new stem cell technology and IVF laboratories and the related accreditation and regulatory aspects of stem cell and IVF laboratories.

He was the scientific director of the global stem cell services company WideCells Group PLC and director of quality at the Fertility and Gynecology Academy in London.

Currently, he works as an independent clinical scientific consultant on assisted reproduction and regenerative medicine projects.

He has written a book on stem cell technology for the general public titled “The Promise of Regeneration,” which was published in December 2020. This is the first in a series of books on medical science. His second book, ‘The Promise of Fertility,’ was published in 2021 and is an explanation of IVF and assisted reproduction for the general reader.

He was awarded the Visiting Chair in Regenerative Medicine at the Kolkata School of Tropical Medicine in November 2017. This was in recognition of his collaborative work on stem cell technology in Kolkata, India.”